These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 22143935)

  • 1. Personalized cancer medicine and the future of pathology.
    Moch H; Blank PR; Dietel M; Elmberger G; Kerr KM; Palacios J; Penault-Llorca F; Rossi G; Szucs TD
    Virchows Arch; 2012 Jan; 460(1):3-8. PubMed ID: 22143935
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Role of Pathology in the Era of Personalized (Precision) Medicine: A Brief Review.
    Vranic S; Gatalica Z
    Acta Med Acad; 2021 Apr; 50(1):47-57. PubMed ID: 34075763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Precision diagnostics: integration of tissue pathology and genomics in cancer.
    Sharma S; George P; Waddell N
    Pathology; 2021 Dec; 53(7):809-817. PubMed ID: 34635323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A national agenda for the future of pathology in personalized medicine: report of the proceedings of a meeting at the Banbury Conference Center on genome-era pathology, precision diagnostics, and preemptive care: a stakeholder summit.
    Tonellato PJ; Crawford JM; Boguski MS; Saffitz JE
    Am J Clin Pathol; 2011 May; 135(5):668-72. PubMed ID: 21502420
    [No Abstract]   [Full Text] [Related]  

  • 5. [Molecular-Genetic Diagnosis and Molecular-Targeted Therapy in Cancer: Challenges in the Era of Precision Medicine].
    Miyachi H
    Rinsho Byori; 2015 Oct; 63(10):1188-93. PubMed ID: 26897855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostics and personalized medicine: observations from the World Companion Diagnostics Summit.
    Curran ME; Platero S
    Pharmacogenomics; 2011 Apr; 12(4):465-70. PubMed ID: 21521019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Genomics and personalized medicine].
    Mooser V
    Praxis (Bern 1994); 2014 May; 103(10):567-71. PubMed ID: 24800768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Personalized urooncology based on molecular uropathology: what is the future?].
    Dahl E; Haller F
    Urologe A; 2013 Jul; 52(7):976-81. PubMed ID: 23831986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Applications of Personalized Medicine: A New Paradigm and Challenge.
    Di Sanzo M; Cipolloni L; Borro M; La Russa R; Santurro A; Scopetti M; Simmaco M; Frati P
    Curr Pharm Biotechnol; 2017; 18(3):194-203. PubMed ID: 28240172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preparing pathology for precision medicine: challenges and opportunities.
    Kaul KL
    Virchows Arch; 2017 Aug; 471(2):141-146. PubMed ID: 28512674
    [No Abstract]   [Full Text] [Related]  

  • 11. Personalized oncology: recent advances and future challenges.
    Kalia M
    Metabolism; 2013 Jan; 62 Suppl 1():S11-4. PubMed ID: 22999010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enabling Precision Oncology Through Precision Diagnostics.
    Brown NA; Elenitoba-Johnson KSJ
    Annu Rev Pathol; 2020 Jan; 15():97-121. PubMed ID: 31977297
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Time for change: a new training programme for morpho-molecular pathologists?
    Moore DA; Young CA; Morris HT; Oien KA; Lee JL; Jones JL; Salto-Tellez M
    J Clin Pathol; 2018 Apr; 71(4):285-290. PubMed ID: 29113995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pathology is precision medicine at the service of the patient].
    Idoate Gastearena MA
    Rev Esp Patol; 2020; 53(1):1-2. PubMed ID: 31932003
    [No Abstract]   [Full Text] [Related]  

  • 15. The leading role of pathology in assessing the somatic molecular alterations of cancer: Position Paper of the European Society of Pathology.
    Matias-Guiu X; Stanta G; Carneiro F; Ryska A; Hoefler G; Moch H;
    Virchows Arch; 2020 Apr; 476(4):491-497. PubMed ID: 32124002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Update on molecular companion diagnostics - a future in personalized medicine beyond Sanger sequencing.
    Campbell MR
    Expert Rev Mol Diagn; 2020 Jun; 20(6):637-644. PubMed ID: 32167388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Health technology assessment in the era of personalized health care.
    Becla L; Lunshof JE; Gurwitz D; Schulte In den Bäumen T; Westerhoff HV; Lange BM; Brand A
    Int J Technol Assess Health Care; 2011 Apr; 27(2):118-26. PubMed ID: 21450126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A 2015 update on predictive molecular pathology and its role in targeted cancer therapy: a review focussing on clinical relevance.
    Dietel M; Jöhrens K; Laffert MV; Hummel M; Bläker H; Pfitzner BM; Lehmann A; Denkert C; Darb-Esfahani S; Lenze D; Heppner FL; Koch A; Sers C; Klauschen F; Anagnostopoulos I
    Cancer Gene Ther; 2015 Sep; 22(9):417-30. PubMed ID: 26358176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Companion diagnostics - the future of modern medicine?].
    Versicherungsmedizin; 2014 Mar; 66(1):42-3. PubMed ID: 24683900
    [No Abstract]   [Full Text] [Related]  

  • 20. Inferring the effect of genomic variation in the new era of genomics.
    Chakravorty S; Hegde M
    Hum Mutat; 2018 Jun; 39(6):756-773. PubMed ID: 29633501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.